ACCJ vs. COVID-19

abbvie vs. COVID-19
ACCJ vs. COVID-19 Steve Wright ACCJ vs. COVID-19 Steve Wright

abbvie vs. COVID-19

AbbVie made significant contributions to the pandemic relief effort in 2020, including, but not limited to, the donation of 8.3 million yen to the Japan Medical Association to support healthcare professionals on the COVID-19 frontlines from the company welfare program fee and the donation of 2,000 hand-cleaning stamps to children’s nursing homes.

Read More
AstraZeneca vs. COVID-19
ACCJ vs. COVID-19 Steve Wright ACCJ vs. COVID-19 Steve Wright

AstraZeneca vs. COVID-19

AstraZeneca’s COVID-19 vaccine was granted special approval for emergency use in Japan for the active immunization of individuals aged 18 years and older on May 21, 2021. Working together with our partners, we hope to contribute to the efforts to end the COVID-19 pandemic in Japan. We are also developing an antibody drug for COVID-19 for the prevention and treatment of COVID-19.

Read More
Bayer vs. COVID-19
ACCJ vs. COVID-19 Steve Wright ACCJ vs. COVID-19 Steve Wright

Bayer vs. COVID-19

In close collaboration with authorities, industry partners, and other stakeholders, Bayer is engaged in financial and product donations, research cooperations, ensuring medicinal supply, and community support and joining forces with the global community in fighting back against COVID-19. In Japan, Bayer Yakuhin donated JPY 5 million to the nonprofit organization Peace Winds Japan for purchasing medical gowns to support healthcare professionals, 200 medical gowns to Shiga Prefecture where it operates a pharmaceutical production site, and 6,000L of highly concentrated ethanol solution to Tokyo, Osaka and Peace Winds Japan.

Read More
Bristol Myers Squibb vs. COVID-19
ACCJ vs. COVID-19 Steve Wright ACCJ vs. COVID-19 Steve Wright

Bristol Myers Squibb vs. COVID-19

During the current world health crisis, Bristol Myers Squibb continues to take all necessary actions to promote public health by carrying out its mission of providing life-saving medicines to the patients who depend on the company, conducting research and supporting relief efforts across the globe.

Read More
Eli Lilly vs. COVID-19
Steve Wright Steve Wright

Eli Lilly vs. COVID-19

Lilly is bringing the full force of its scientific and medical expertise to attack the coronavirus pandemic around the world. Existing Lilly medicines are being studied to understand their potential in treating complications of COVID-19, and the company is collaborating with partner companies to discover and develop novel antibody treatments for COVID-19. In Japan, we have been enforcing strict measures to prevent infection. The effort includes the sterilization of workplaces, providing care for employees and their families, digitalization of communication tools (virtual meeting with our customers), and support for the community.

Read More
Proctor & Gamble vs. COVID-19
ACCJ vs. COVID-19 Steve Wright ACCJ vs. COVID-19 Steve Wright

Proctor & Gamble vs. COVID-19

The P&G Group, in cooperation with the government and NPO corporations, has worked to deliver relief supplies necessary to combat the effects of Covid-19. As of March 27, we have delivered the following relief supplies: surgical masks, ethanol disinfectant, face shields, and more. We have also donated millions of yen to the Kobe Medical Professional Support Fund and Save the Children.

Read More
Stryker Japan
ACCJ vs. COVID-19 Steve Wright ACCJ vs. COVID-19 Steve Wright

Stryker Japan

Stryker Japan is committed to helping Japan address COVID-19. Stryker Japan has made donations of personal protection equipment (PPE), such as gowns, to Hokkaido where the demand was critically high.

Read More